Company Monitoring Page for Novartis

latest headlines for company on cafepharma

In R&D rethink, Novartis ditches part of $2.6B Xencor bispecific pact
Fierce Biotech
Tue, 01/8/19 - 10:31 am
Tags:
Novartis, Xencor, bispecific antibodies
Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises
Fierce Pharma
Tue, 01/8/19 - 12:38 am
Tags:
Novartis, Pharma CEOs, CAR-T, Kymriah, Vas Narasimhan, JPMHC 2019
Novartis shares data on discontinued antibiotic research
BioCentury
Thu, 01/3/19 - 11:42 pm
Tags:
Novartis, R&D, antibiotics
For CAR-T Cancer Fighters in the Real World, Two Roads Diverge
Xconomy
Thu, 01/3/19 - 04:16 pm
Tags:
cancer, CAR-T, Gilead Sciences, Yescarta, Novartis, Kymriah
Why did Liz Barrett turn her back on a top job at Novartis in exchange for the helm of a biotech you never heard of?
Endpoints
Thu, 01/3/19 - 04:10 pm
Tags:
Liz Barrett, Novartis, Urogen
Novartis (NVS) Benefits From New Drugs & Key Acquisitions
Yahoo/Zacks.com
Mon, 12/31/18 - 12:13 pm
Tags:
Novartis, M&A
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
BioSpace
Fri, 12/28/18 - 01:30 pm
Tags:
breast cancer, lung cancer, AstraZeneca, Tagrisso, Novartis, Gleevec, Tasigna, Bristol-Myers Squibb, Sprycel, Pfizer, Bosulif, Takeda, Iclusig
Big Pharma returning to U.S. price hikes in January after pause
Reuters
Fri, 12/21/18 - 10:20 am
Tags:
drug pricing, Novartis, Bayer, Donald Trump
ICER says gene therapy may be more cost effective for spinal muscular atrophy
Yahoo/Reuters
Thu, 12/20/18 - 11:54 pm
Tags:
Biogen, Spinraza, Novartis, spinal muscular atrophy, ICER
Novartis seeks to acquire French CAR-T contract manufacturer
Biopharma Dive
Thu, 12/20/18 - 11:43 pm
Tags:
Novartis, M&A, France, CellforCure, CMO, Kymriah, CAR-T
Novartis unit Alcon picks up Tear Film Innovations
Mass Device
Thu, 12/20/18 - 11:48 am
Tags:
Novartis, Alcon, M&A, eye health, Tear Film Innovations, devices
Novartis oncology CEO quits after less than a year
Pharmaforum
Thu, 12/20/18 - 10:07 am
Tags:
Novartis, oncology, Susanne Schaffert, Liz Barrett
Alcon's Acquisition Is a Real Tear-Jerker
Medical Devices and Diagnostics Industry
Thu, 12/20/18 - 12:22 am
Tags:
Alcon, Novartis, eye health
As promised, Novartis eyes new method for funding ultrapricey next-gen drugs: FT
Fierce Pharma
Wed, 12/19/18 - 12:23 am
Tags:
Novartis, gene therapies, insurance
Novartis unit teams up with medical marijuana producer, marking milestone for pharma
Stat
Tue, 12/18/18 - 12:53 pm
Tags:
Novartis, Sandoz, Medical Marijuana, Tilray Canada
Novartis, still struggling with Kymriah manufacturing, is providing some out-of-spec doses to patients who ask
Fierce Pharma
Tue, 12/18/18 - 12:51 pm
Tags:
Novartis, patients, CAR-T, Kymriah, drug manufacturing
2 Sets of Disasters Biotech Will Pay For in 2019
Yahoo/Motley Fool
Mon, 12/17/18 - 12:16 am
Tags:
Gilead Sciences, Yescarta, Novartis, Kymriah, Spark Therapeutics, Luxturna
Novartis gets EC approval for self-administration of Xolair across all indications
Pharmaceutical Business Review
Fri, 12/14/18 - 12:39 pm
Tags:
Novartis, Xolair, severe allergic asthma, chronic spontaneous urticaria
Novartis CEO calls for cultural shift to cater for millennial generation
Pharmafile
Sat, 12/8/18 - 12:22 pm
Tags:
Novartis, Pharma CEOs, Vas Narasimhan, millennials
Novartis sheds light on liquid biopsies with SOLAR-1 analysis
Biopharma Dive
Fri, 12/7/18 - 12:03 pm
Tags:
Novartis, alpelisib, breast cancer, liquid biopsy

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.